Lindbrook Capital’s Wave Life Sciences WVE Stock Holding History

Lindbrook Capital’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$4.39K	Buy	543 +38	+8%	+$416	﹤0.01%	2001
2024 Q4	$6.25K	Hold	505	–	–	﹤0.01%	1884
2024 Q3	$4.14K	Hold	505	–	–	﹤0.01%	2089
2024 Q2	$2.52K	Buy	505 +94	+23%	+$536	﹤0.01%	2274
2024 Q1	$2.54K	Hold	411	–	–	﹤0.01%	2159
2023 Q4	$2.08K	Hold	411	–	–	﹤0.01%	2248
2023 Q3	$2.36K	Hold	411	–	–	﹤0.01%	2063
2023 Q2	$1.5K	Buy	411 +261	+174%	+$1.05K	﹤0.01%	2263
2023 Q1	$650	Buy	+150	New	+$687	﹤0.01%	2554

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Lindbrook Capital's WVE Position: Q1 2025 in Review

Lindbrook Capital increased its Wave Life Sciences (WVE) stake by 7.5% in Q1 2025, buying an estimated $416 and bringing the position to 543 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

Lindbrook Capital first reported a position in WVE in Q1 2023 and has held it in 9 quarters since. The position peaked at $6.25K in Q4 2024. 196 funds tracked by Wall St. Rank hold WVE as of Q1 2025.

Lindbrook Capital held 543 shares of Wave Life Sciences worth $4.39K as of Q1 2025.
Lindbrook Capital bought 38 Wave Life Sciences shares in Q1 2025, an estimated $416.
Wave Life Sciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2001 holding.
Lindbrook Capital first reported a position in Wave Life Sciences in Q1 2023 and has held it in 9 quarters since.
Lindbrook Capital's Wave Life Sciences position peaked at $6.25K in Q4 2024.
196 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.